Major market players are spending a lot of money on R&D to increase their product lines, which will help the Bromelain market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the Bromelain industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
One of the primary business strategies adopted by manufacturers in the Bromelain industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, Bromelain industry has provided innovative products with some of the most significant benefits. The Bromelain market major player such as Enzybel Group (Belgium), Changsha Natureway Co. Ltd. (China), Nutriteck (Canada), Enzyme Development Corporation (U.S.), Fooding Group Limited (China), Krishna Enzytech Pvt. Ltd. (India), Creative Enzymes (U.S.), Hong Mao Biochemicals Co.
Ltd. (Thailand), Food State Company (U.K.), Advanced Enzyme Technologies (India) and others are working to expand the market demand by investing in research and development activities.
Enzybel Group is a Belgium-based company that specializes in the production of plant-derived enzymes for various applications, including food and beverage, pharmaceuticals, and cosmetics. The company's product portfolio includes a range of enzymes, including bromelain, papain, and ficin. The company operates globally, with production facilities in Belgium, Brazil, and China. In August 2021, Enzybel Group announced the launch of its new bromelain product, Bromelain K, which has been developed specifically for the food industry.
The new product is a high-quality and stable bromelain enzyme that can be used as a meat tenderizer, protein hydrolyzer, and flavor enhancer in various food applications.
Enzyme Development Corporation (EDC) is a biotech company that specializes in the development and production of enzymes for various industries, including food, pharmaceuticals, and agriculture. EDC has been in operation for over 40 years and has become a leader in the enzyme industry due to its innovative products and exceptional customer service. One notable product in EDC's portfolio is bromelain, an enzyme derived from pineapple stems that has been shown to have anti-inflammatory and digestive benefits. Bromelain is commonly used as a dietary supplement and in the food industry as a meat tenderizer.
In July 2022, EDC announced that it had completed a clinical trial on the effectiveness of its bromelain product in reducing joint pain and inflammation in patients with osteoarthritis. The results of the trial were promising, showing a significant reduction in pain and stiffness in the participants who received the bromelain supplement compared to the placebo group..